NEW YORK (GenomeWeb News) — A Wisconsin court has upheld a $7-million verdict against Abbott Laboratories for infringing a patent held by Innogenetics that protects a process for typing HCV isolates, the Belgian biotech said yesterday.
 
The court also denied Abbott’s motion for a new trial based on “infringement and validity” and granted Innogenetics’ motion to set another hearing to consider permanently barring Abbott from selling the infringing products, Innogenetics said.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.